These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 31923035

  • 1. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Porcu P, Martinez NL, Glass J, Mashayekhi A, Shields CL.
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [Abstract] [Full Text] [Related]

  • 2. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CL.
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [Abstract] [Full Text] [Related]

  • 3. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY, Kim JJ, Kim RY, Kim M, Park YG, Park YH.
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2421-2429. PubMed ID: 38446203
    [Abstract] [Full Text] [Related]

  • 4. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
    Dalvin LA, Pulido JS, Shields CL, Marchese A, Miserocchi E, Frenkel S, Pe'er J.
    Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
    [Abstract] [Full Text] [Related]

  • 5. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes.
    Fadlelseed H, Rhatigan M, Treacy M, Murphy C, O'Neill J, Kilmartin D, Kennedy S.
    Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590
    [Abstract] [Full Text] [Related]

  • 6. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ, Kim DY, Park UC, Lee JY, Yoon YH, Yu HG.
    Ocul Immunol Inflamm; 2018 Sep; 26(3):365-371. PubMed ID: 29394118
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A, Heissigerova J, Rihova E, Brichova M, Pytlik R, Spicka I, Mrazova K, Karolova J, Svozilkova P.
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [Abstract] [Full Text] [Related]

  • 8. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
    Guan W, Xiao Y, Zhao H, Hu F, Chen C, Peng X.
    Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
    [Abstract] [Full Text] [Related]

  • 9. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A, Pulido JS, Johnston PB, Ristow KM, Nora Bennani N, Inwards DJ, Macon WR, Micallef INM, King RL, Salomao DR, Witzig TE, Habermann TM, Nowakowski GS.
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [Abstract] [Full Text] [Related]

  • 10. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F, Dolz-Marco R, Francis JH, Au A, Davis JL, Fawzi A, Gattousi S, Goldstein DA, Keane PA, Miserocchi E, Marchese A, Ohno-Matsui K, Sagoo MS, Smith SD, Sobol EK, Tasiopoulou A, Yang X, Shields CL, Freund KB, Sarraf D.
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [Abstract] [Full Text] [Related]

  • 11. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C, Cicinelli MV, Marchese A, Modorati GM, Brambati M, Ferreri AJM, Calimeri T, Ponzoni M, Bandello F, Miserocchi E.
    Ocul Immunol Inflamm; 2021 Apr 03; 29(3):472-478. PubMed ID: 32845738
    [Abstract] [Full Text] [Related]

  • 12. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
    Marchese A, Miserocchi E, Giuffrè C, Cicinelli MV, Querques G, Bandello F, Modorati G.
    Br J Ophthalmol; 2019 Nov 03; 103(11):1656-1659. PubMed ID: 30709808
    [Abstract] [Full Text] [Related]

  • 13. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK, Hovelson DH, Demirci H, Johnson MW, Tomlins SA, Rao RC.
    Oncotarget; 2017 Jan 31; 8(5):7989-7998. PubMed ID: 28002793
    [Abstract] [Full Text] [Related]

  • 14. The Silent Masquerade: Clinical and Imaging Features of Asymptomatic Vitreoretinal Lymphoma.
    Menean M, Cicinelli MV, Rivolta MC, Marchese A, Modorati G, Bandello F, Miserocchi E.
    Am J Ophthalmol; 2024 Nov 31; 267():153-159. PubMed ID: 38977150
    [Abstract] [Full Text] [Related]

  • 15. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.
    El Zein L, Smith WM, White LJ, Hodge DO, Olsen TW, Pulido JS, Dalvin LA.
    BMC Ophthalmol; 2024 Jun 13; 24(1):255. PubMed ID: 38872120
    [Abstract] [Full Text] [Related]

  • 16. Vitreoretinal Lymphoma with Intraretinal Infiltration, Simulating Retinal Necrosis.
    Guan WX, Peng XY.
    Ophthalmol Retina; 2024 Jun 13; 8(6):571-578. PubMed ID: 38040056
    [Abstract] [Full Text] [Related]

  • 17. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S, Gu J, Zhang T, Ping B, Zhou M, Huang X, Jiang R, Xu G, Chang Q.
    Retina; 2021 Dec 01; 41(12):2596-2604. PubMed ID: 34173362
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T, Taoka K.
    Jpn J Ophthalmol; 2023 Jul 01; 67(4):363-381. PubMed ID: 37209195
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z, Frenkel S, Pe'er J.
    Br J Haematol; 2021 Jul 01; 194(1):92-100. PubMed ID: 33900619
    [Abstract] [Full Text] [Related]

  • 20. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
    Yang X, Dalvin LA, Mazloumi M, Ferenczy S, Lim LS, Ancona-Lezama D, Shields JA, Mashayekhi A, Shields CL.
    Retina; 2021 Feb 01; 41(2):249-258. PubMed ID: 32349103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.